Hefiya
Active substance: adalimumab
adalimumab
Centralised EU authorisationActive
Marketing holder: Sandoz GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 9 |
|
| US 64 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3043-78d9-ad69-dcaa5dac2fd4,01a120c3-378f-7699-9d95-0f9f0fc78133,01a120c3-5e58-7a8c-9a16-73aa1cecf95a,01a120c3-5e7f-7b28-8975-ca7e09e80572,01a120c3-5f66-787c-97e5-5657be71ce54;count=9 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b7e-7816-83ec-f30d736add76,01a1208c-3b89-715e-9025-9ee0fa6afb94,01a1208c-3b8a-732f-ab27-46026e9ab96c,01a1208c-7834-74ff-ba7e-a3d548500777,01a1208c-857d-7cd2-b91e-8718d5cf56f4;count=64 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004865
- Registration status
- Active
- ATC code
- L04AB04
Sources
- product · EMA · EMEA/H/C/004865 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004865 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004865 · Verified 2026-10-09